Literature DB >> 24206171

Metabolic syndrome as an underlying disease entity and its relationship to subclinical atherosclerosis in Andean Hispanics.

Diana A Chirinos1, Josefina Medina-Lezama, William Arguelles, Ronald Goldberg, Neil Schneiderman, Zubair Khan, Oscar O Morey, Muhammad Waheed Raja, Roberto Paz, Julio A Chirinos, Maria M Llabre.   

Abstract

BACKGROUND: The question of whether the metabolic syndrome truly reflects a single disease entity with a common underlying pathology remains unclear. In this study, we assess whether metabolic syndrome represents an underlying disease construct in a large population-based sample of Andean Hispanic adults and examine its relationship to subclinical atherosclerosis.
METHODS: The study sample was comprised of 2513 participants. Confirmatory factor analysis (CFA) was used to identify a metabolic syndrome latent factor using waist circumference, systolic and diastolic blood pressure, high-density lipoprotein cholesterol (HDL-C), triglycerides (TGs), and glucose levels as indicators. The relationship with subclinical atherosclerosis, measured by carotid intima media thickness (cIMT), was assessed using structural equation modeling.
RESULTS: Results supported the proposed structure of the metabolic syndrome latent factor evidenced by adequate fit indexes. HDL-C did not significantly load on the metabolic syndrome latent factor (standardized factor loading=0.01, P=0.88). The metabolic syndrome latent factor was significantly associated with cIMT in women (B=0.007, P<0.001) and men (B=0.008, P<0.001) after controlling for age, low-density lipoprotein cholesterol and smoking.
CONCLUSIONS: Our findings suggest that metabolic syndrome components, such as waist circumference, blood pressure, TGs, and glucose levels, but not HDL-C, share a common underlying pathophysiology that may contribute to the progression of atherosclerosis in Andean Hispanics. Its longitudinal association with cardiovascular disease should be the focus of future research.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24206171      PMCID: PMC4361393          DOI: 10.1089/met.2013.0092

Source DB:  PubMed          Journal:  Metab Syndr Relat Disord        ISSN: 1540-4196            Impact factor:   1.894


  36 in total

1.  Carotid wall thickness is predictive of incident clinical stroke: the Atherosclerosis Risk in Communities (ARIC) study.

Authors:  L E Chambless; A R Folsom; L X Clegg; A R Sharrett; E Shahar; F J Nieto; W D Rosamond; G Evans
Journal:  Am J Epidemiol       Date:  2000-03-01       Impact factor: 4.897

2.  The metabolic syndrome and coronary artery disease: a structural equation modeling approach suggestive of a common underlying pathophysiology.

Authors:  Jennifer E Stevenson; Bruce R Wright; Alan S Boydstun
Journal:  Metabolism       Date:  2012-05-23       Impact factor: 8.694

3.  Is the factor structure of the metabolic syndrome comparable between men and women and across three ethnic groups: the Miami Community Health Study.

Authors:  Biing-Jiun Shen; Ronald B Goldberg; Maria M Llabre; Neil Schneiderman
Journal:  Ann Epidemiol       Date:  2005-10-27       Impact factor: 3.797

4.  Cardiovascular morbidity and mortality associated with the metabolic syndrome.

Authors:  B Isomaa; P Almgren; T Tuomi; B Forsén; K Lahti; M Nissén; M R Taskinen; L Groop
Journal:  Diabetes Care       Date:  2001-04       Impact factor: 19.112

5.  Geographic variations of the International Diabetes Federation and the National Cholesterol Education Program-Adult Treatment Panel III definitions of the metabolic syndrome in nondiabetic subjects.

Authors:  Carlos Lorenzo; Manuel Serrano-Ríos; María T Martínez-Larrad; José L González-Sánchez; Segundo Seclén; Arturo Villena; Clicerio Gonzalez-Villalpando; Ken Williams; Steven M Haffner
Journal:  Diabetes Care       Date:  2006-03       Impact factor: 19.112

6.  Comparison of modifiable determinants of lipids and lipoprotein levels among African-Americans, Hispanics, and Non-Hispanic Caucasians > or =65 years of age living in New York City.

Authors:  Carlos Rodriguez; Ariel Pablos-Méndez; Walter Palmas; Rafael Lantigua; Richard Mayeux; Lars Berglund
Journal:  Am J Cardiol       Date:  2002-01-15       Impact factor: 2.778

Review 7.  Design of PREVENCION: a population-based study of cardiovascular disease in Peru.

Authors:  Josefina Medina-Lezama; Julio A Chirinos; Humberto Zea Díaz; Oscar Morey; Juan F Bolanos; Edgar Munoz-Atahualpa; Julio Chirinos-Pacheco
Journal:  Int J Cardiol       Date:  2005-11-02       Impact factor: 4.164

8.  Association between metabolic syndrome and subclinical coronary atherosclerosis in asymptomatic adults.

Authors:  Iftikhar J Kullo; Andrea E Cassidy; Patricia A Peyser; Stephen T Turner; Patrick F Sheedy; Lawrence F Bielak
Journal:  Am J Cardiol       Date:  2004-12-15       Impact factor: 2.778

9.  Metabolic syndrome, diabetes and subclinical atherosclerosis as assessed by carotid intima-media thickness.

Authors:  Ryuichi Kawamoto; Hitomi Tomita; Nobuyuki Ohtsuka; Ai Inoue; Atsushi Kamitani
Journal:  J Atheroscler Thromb       Date:  2007-04       Impact factor: 4.928

10.  Insulin resistance, metabolic syndrome, and subclinical atherosclerosis: the Multi-Ethnic Study of Atherosclerosis (MESA).

Authors:  Alain G Bertoni; Nathan D Wong; Steven Shea; Shuangge Ma; Kiang Liu; Srikanthan Preethi; David R Jacobs; Colin Wu; Mohammed F Saad; Moyses Szklo
Journal:  Diabetes Care       Date:  2007-08-17       Impact factor: 19.112

View more
  3 in total

1.  Gender- and race-specific metabolic score and cardiovascular disease mortality in adults: A structural equation modeling approach--United States, 1988-2006.

Authors:  Carla I Mercado; Quanhe Yang; Earl S Ford; Edward Gregg; Amy L Valderrama
Journal:  Obesity (Silver Spring)       Date:  2015-09       Impact factor: 5.002

2.  [Type 2 diabetes mellitus in peru: a systematic review of prevalence and incidence in the general population].

Authors:  Rodrigo M Carrillo-Larco; Antonio Bernabé-Ortiz
Journal:  Rev Peru Med Exp Salud Publica       Date:  2019-05-13

3.  Prevalence of high-risk coronary plaques in patients with and without metabolic syndrome and the relationship with prognosis.

Authors:  Xu Yang; Wei Luo; Shan Han; Lei Zha; Jing Zhang; Xiaowei Li; Hui Zhao; Shuo Liang; Ru Zhao
Journal:  BMC Cardiovasc Disord       Date:  2020-02-11       Impact factor: 2.298

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.